Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NAV3 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5103969
Description
Antibody detects endogenous levels of total NAV3.
Neuron navigator 3 (NAV3), also known as pore membrane and/or filamentinteracting-like protein 1 (POMFIL1), unc-53 homolog 3 (unc53H3) or STEERIN3, is a 2,385 amino acid protein that localizes to the nuclear outer membrane and plays a role in neuron regeneration. Existing as three alternatively spliced isoforms, Neuron navigator 3 is highly expressed in adult and fetal brain and is found at moderate to low levels in ovary, lung, testis, placenta and heart. Neuron navigator 3 is thought be involved in the regulation of IL-2 production and contains one CH (calponin-homology) domain, three N-terminal hydrophobic domains, multiple N-glycosylation sites, three ATP/GTP-binding A motifs (P loops) and several phosphorylation sites.
Specifications
| NAV3 | |
| Polyclonal | |
| Unconjugated | |
| NAV3 | |
| 4732483H20Rik; 9630020C08Rik; KIAA0938; mKIAA0938; NAV3; Neuron navigator 3; POMFIL1; Pomfil1p; pore membrane and/or filament interacting like protein 1; pore membrane and/or filament-interacting-like protein 1; RGD1306259; steerin 3; STEERIN3; Steerin-3; Unc-53 homolog 3; unc53H3 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 89795 | |
| -20°C | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q8IVL0 | |
| NAV3 | |
| A synthesized peptide derived from human NAV3(Accession Q8IVL0), corresponding to amino acid residues M1497-S1547. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction